Symptoms: Neurogenic Claudication and Beyond
The hallmark symptom of lumbar spinal stenosis is neurogenic claudication-pain, heaviness, or weakness in the legs that develops with walking or prolonged standing and improves with sitting or bending forward. This positional quality is key: flexion (bending forward) opens the spinal canal slightly, while extension (standing upright or walking) narrows it. Patients often describe an increasing "shopping cart sign" - leaning forward on a cart provides relief because it opens the canal.
Beyond claudication, stenosis can produce radiculopathy (radiating pain along a specific nerve root distribution), numbness or tingling in the legs or feet, and in severe cases, difficulty with balance or bladder function. Cervical stenosis can produce myelopathic symptoms: clumsiness in the hands, difficulty with fine motor tasks, gait instability, and in advanced cases, upper motor neuron signs.
Diagnosis requires MRI to visualize the degree and location of narrowing, combined with clinical correlation. I pay particular attention to what is causing the narrowing-disc bulging versus bony overgrowth versus ligamentous hypertrophy-because this determines the treatment approach. We also assess dynamic factors: does the stenosis worsen with extension and improve with flexion? Are there associated findings like spondylolisthesis (vertebral slippage) that contribute to canal compromise?
When Regenerative Medicine Can-and Cannot-Help
Be honest about limitations: Not all spinal stenosis is treatable with regenerative medicine. Severe, fixed bony stenosis with significant canal compromise may require surgical decompression. Progressive myelopathy (spinal cord compression in the cervical spine) typically requires surgical intervention.
However, many patients with mild to moderate stenosis-particularly those whose narrowing is driven primarily by disc degeneration, facet arthropathy, and soft tissue changes-have meaningful treatment options short of surgery. The regenerative approach targets the degenerative processes that are causing the canal to narrow, rather than simply removing tissue to create more space.
In appropriate candidates, regenerative treatment can reduce the inflammatory component contributing to nerve irritation, address the facet arthropathy that drives osteophyte formation, improve disc integrity to slow further height loss, and support the ligamentous structures that stabilize the affected segment.
Dr. Crane's Approach to Stenosis
My approach to spinal stenosis begins with a detailed characterization of what is causing the narrowing and whether the stenosis is the actual source of the patient's symptoms. Not every patient with stenosis on MRI has symptomatic stenosis-and not every patient with leg pain and stenosis has pain from the stenosis. Diagnostic precision matters.
For stenosis driven primarily by facet arthropathy, intra-articular regenerative injections into the facet joints can reduce synovial inflammation, slow osteophyte progression, and improve the capsular integrity of the joint. This addresses one of the primary contributors to foraminal and lateral recess stenosis.
For stenosis with significant disc degeneration, regenerative treatment can deliver cellular resources and growth factors that support disc integrity and reduce the inflammatory milieu within and around the degenerating disc. By addressing disc degeneration, we can slow the progressive height loss that collapses the neural foramen.
For the associated ligamentous laxity and segmental instability that often accompanies stenosis, regenerative injection therapy strengthens the supporting spinal ligaments and improves segmental stability. A more stable segment is a less inflamed segment.
Emerging research on exosome-mediated anti-inflammatory signaling suggests potential applications for the neuroinflammatory component of stenosis - the perineural inflammation that amplifies symptoms beyond what the mechanical narrowing alone would predict. This is an area we are actively monitoring.
What to Expect
Treatment begins with comprehensive evaluation including imaging review, physical examination, and potentially diagnostic injections to confirm the pain-generating structures. If you are a candidate for regenerative treatment, we develop a protocol that addresses each contributing factor - disc degeneration, facet arthropathy, ligamentous instability - as part of an integrated approach.
Walking tolerance, standing tolerance, and neurogenic claudication severity are the primary outcomes we track. Some patients achieve dramatic improvement; others achieve meaningful but partial relief that allows them to maintain activity and defer or avoid surgery.